Statements (29)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:investor
|
gptkbp:country |
gptkb:Switzerland
|
gptkbp:focusesOn |
gptkb:biotechnology
life sciences medical device |
gptkbp:foundedBy |
gptkb:Novartis
|
gptkbp:foundedYear |
1996
|
gptkbp:headquartersLocation |
Basel
|
https://www.w3.org/2000/01/rdf-schema#label |
Novartis Venture Fund
|
gptkbp:industry |
venture capital
|
gptkbp:investedIn |
startups
private companies early stage growth stage |
gptkbp:parentOrganization |
gptkb:Novartis
|
gptkbp:portfolioCompany |
gptkb:CytomX_Therapeutics
gptkb:Adimab gptkb:Molecular_Partners gptkb:Heptares_Therapeutics gptkb:Nexthink Celyad F2G Nabriva Therapeutics Polyphor Vaximm |
gptkbp:website |
https://www.nvfund.com/
|
gptkbp:bfsParent |
gptkb:Faze_Medicines
gptkb:Flare_Therapeutics |
gptkbp:bfsLayer |
7
|